Press release
Neurological Biomarker Market Soaring at US$ 5,501.8 million by 2027 with Leading Key Players: Quest Diagnostics Incorporated, PerkinElmer, Inc., Bio-Rad Laboratories Inc., Qiagen Banyan Biomarkers Inc, Merck Millipore
The Neurological Biomarker Market is expected to reach US$ 5,501.8 million by 2027 from US$ 14,454.7 million in 2019. The market is estimated to grow at a CAGR of 13.0% from 2020 to 2027.Biomarkers are disease-specific molecular indicators. In the early days, neurological disease biomarkers were not that accessible; however, the advancements in technology have enabled the measurement of specific biomarkers for tracking the health of the brain. This helps in the early detection of disease and less invasive diagnostics and enables faster drug development. The global neurological biomarker market is driven by factors such as the increasing prevalence of neurological diseases and the growing focus on neurological biomarker research are expected to propel the growth of the market during the forecast period.
The Global Neurological Biomarker Market research report offers deep prudence of the global Neurological Biomarker industry’s attractiveness, profitability, revenue, and growth momentum to market players which helps them to foresight the market performance during the forecast period of up to 2021-2027. The report studies historical and present market status and offers reliable market forecasts considering market trends, sales volume, demand, market size, and share.
(**Note: The sample of this report is updated with COVID-19 impact analysis**)
To Know How COVID-19 Pandemic Will Impact Global Neurological Biomarker Market | Get a Sample Copy of Report, Click Here:
https://www.theinsightpartners.com/sample/TIPRE00003515/?source=openpr-10411
Top players of Neurological Biomarker Market:-
• Thermo Fisher Scientific Inc.
• Abbott
• Myriad Genetics Inc.
• Bio-Rad Laboratories Inc.
• Qiagen Banyan Biomarkers Inc.
• Immunarray Pvt. Ltd.
• Quest Diagnostics Incorporated
• PerkinElmer, Inc.
• Merck Millipore
Global Neurological Biomarker Market– ByProduct
• Proteomics Biomarker
• Genomics Biomarker
• Metabolomics Biomarker
• Imaging Biomarker
• Others
Global Neurological Biomarker Market– By Application
• Alzheimer's Disease
• Parkinson's Disease
• Schizophrenia
• Huntington's Disease
• Spinal Muscular Atrophy
• Others
Global Neurological Biomarker Market– By End User
• Pharmaceutical and Biotechnology Companies
• Clinical Diagnostics
• Research Organizations
The report also casts light on significant facets such as competitive landscape, significant Neurological Biomarker manufacturers/companies, segments, sub-segments, industry environment, market overview, upstream and downstream, technological advancements, and overall market operations. The report consists of Neurological Biomarker market insights which have been extracted through reliable information sources and analyzed by the expert analyst’s team who ensure complete authenticity for intact data.
Additionally, the report underscores regional analysis as it holds huge importance in the market segment study. The regional analysis offers a thorough concept over Neurological Biomarker business performance considering market places in North America, Europe, the Middle East, South America, Asia Pacific, and Oceania. It offers valuable predictions for futuristic market growth in each region and explores regional industry environments at a minute level.
Purchase a copy of the report @
https://www.theinsightpartners.com/buy/TIPRE00003515/?source=openpr-10411
The report further explains how leading market players are operating in the market and what their prospects are towards market growth. Players’ organizational structure, Neurological Biomarker production methodologies, plant locations, raw material sources, distribution network, global presence, value chain, pricing structure, product specifications, capacity utilization, corporate alliance, brands, patents, industry supply chain, and import-export activities are analyzed in the report to offer a comprehensive delineation of leading players.
Table of Contents:
Global Neurological Biomarker Market Research Report
Chapter 1 Neurological Biomarker Market Overview
Chapter 2 Global Economic Impact
Chapter 3 Competition by Firms
Chapter 4 Analysis by Regions
Chapter 5 Revenue (Value), Price Trend by Type
Chapter 6 Analysis by Application
Chapter 7 Development Analysis
Chapter 8 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 9 Marketing Strategy Analysis, Distributors/Traders
Chapter 10 Market Effect Factors Analysis
Chapter 11 Market Forecast 2028
Chapter 12 Appendix
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurological Biomarker Market Soaring at US$ 5,501.8 million by 2027 with Leading Key Players: Quest Diagnostics Incorporated, PerkinElmer, Inc., Bio-Rad Laboratories Inc., Qiagen Banyan Biomarkers Inc, Merck Millipore here
News-ID: 2324729 • Views: …
More Releases from The Insight Partners

Global Self-Checkout System Market Driven by Retail Automation and AI Innovation
New York, US - October 16, 2025 - The Insight Partners has published its latest research report titled "Self-Checkout System Market Forecast to 2031 - Global Analysis by Component, Model Type, and End User." The study reveals that the Self-Checkout System Market is expected to grow at a CAGR of 8.2% from 2025 to 2031, driven by rapid retail automation, growing consumer demand for contactless experiences, and advances in AI…

The Rising Tide: HPMC Capsule Market Overview
In recent years, the pharmaceutical, nutraceutical, and supplement industries have seen a clear shift toward plant based, non animal derived dosage forms. Among these, hydroxypropyl methyl cellulose (HPMC) capsules have emerged as a leading non gelatin alternative, largely driven by growing consumer preferences for vegetarian/vegan products, stricter regulatory trends, and technical advantages of HPMC over traditional gelatin shells.
According to a market report by The Insight Partners, the global HPMC Capsule…

Aesthetic Fillers and Exosomes Market Report: Unlocking Growth Potential and Add …
The Insight Partners is proud to announce its newest market report, "Aesthetic Fillers and Exosomes Market: An In-depth Analysis of the Global Aesthetic Fillers and Exosomes Market." The report provides a holistic view of the Aesthetic Fillers and Exosomes Market and describes the current scenario as well as growth estimates of the market during the forecast period.
Check valuable insights in the Aesthetic Fillers and Exosomes Market report. You can easily…

Understanding the Rheumatology Market: Segments & Scope
According to The Insight Partners, the rheumatology market is broadly segmented by:
• Drug class: nonsteroidal anti inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and disease modifying anti rheumatic drugs (DMARDs).
• Disease indications: rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis.
• Distribution channels: hospital pharmacies, retail pharmacies, online pharmacies.
• Geography: the usual regions (North America, Europe, Asia Pacific, South & Central America, etc.) with further country level breakdowns.
CAGR (Compound Annual Growth…
More Releases for Biomarker
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Multiplex Biomarker Imaging Market Size By 2025?
In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of…
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic,…
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints),
Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,…
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.
Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register
MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:
Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge…
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being.
CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,…
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558
This latest report researches the industry structure,…